The natriuretic peptides and hypertension.
Richards
A M
AM
Department of Cardiology, Princess Margaret Hospital, Christchurch, New Zealand.
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000097:blood* / Q000502:physiology / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D020097:Natriuretic Peptide, Brain; D020098:Natriuretic Peptide, C-Type; D015260:Neprilysin / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D009419:Nerve Tissue Proteins / Q000097:blood / Q000502:physiology; D010446:Peptide Fragments / Q000627:therapeutic use
D009419:Nerve Tissue Proteins; D010446:Peptide Fragments; D020097:Natriuretic Peptide, Brain; C059320:SC 46542; D020098:Natriuretic Peptide, C-Type; D009320:Atrial Natriuretic Factor; D015260:Neprilysin